Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_assertion description "[The evidence for prostate cancer risk reduction with the mono 5?-reductase inhibitor (5ARI) finasteride in a low-risk population and, more recently, with the dual 5ARI dutasteride in a population at increased risk of developing the disease, has potential to expand management options for men at risk of developing prostate cancer beyond more frequent and/or earlier surveillance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_assertion evidence source_evidence_literature NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_assertion SIO_000772 21166744 NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_assertion wasDerivedFrom befree-20150227 NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_assertion wasGeneratedBy ECO_0000203 NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.
- befree-20150227 importedOn "2015-02-27" NP712230.RAwsq0x8jov3NljxxBFKxlOdyN5U8b5DgjI8CDsXVWG8w130_provenance.